The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preliminary safety and efficacy of ruxolitinib in patients (pts) with primary and secondary myelofibrosis (MF) with platelet counts (PC) of 50–100x109/L.
Moshe Talpaz
No relevant relationships to disclose
Solomon I. Hamburg
No relevant relationships to disclose
Katarzyna Jamieson
No relevant relationships to disclose
Howard R. Terebelo
Consultant or Advisory Role - Celgene
Honoraria - Amgen; Celgene; Millennium
Lawrence Afrin
No relevant relationships to disclose
Elliott F. Winton
Consultant or Advisory Role - Incyte
Honoraria - Incyte
Michael A. Scola
Stock Ownership - Incyte
Roger M. Lyons
Research Funding - Amgen; Celgene; Incyte; Novartis; Telik
Jimmie Huling Harvey
No relevant relationships to disclose
Chris E. Holmes
No relevant relationships to disclose
Gregory L. Ortega
No relevant relationships to disclose
Josef T. Prchal
No relevant relationships to disclose
Richard T. Silver
Consultant or Advisory Role - Incyte
Stock Ownership - Incyte
Honoraria - Incyte
Research Funding - Incyte
Maria R. Baer
Consultant or Advisory Role - Incyte (U)
Research Funding - Incyte
Susan Kay Erickson-Viitanen
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
Peter O'Neill
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
Wei Peng
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
Lance Leopold
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
Hagop Kantarjian
Research Funding - Incyte
Srdan Verstovsek
Research Funding - Incyte